-
EC eCQMs
-
Resolution: Answered
-
Moderate
-
None
-
We plan to move forward with the proposed change during this annual update.
Brief Description of Measure:
CMS124: Cervical Cancer Screening:
Percentage of women 21-64 years of age who were screened for cervical cancer using either of the following criteria:
- Women age 21-64 who had cervical cytology performed within the last 3 years
- Women age 30-64 who had cervical human papillomavirus (HPV) testing performed within the last 5 years
CMS125: Breast Cancer Screening:
Percentage of women 50-74 years of age who had a mammogram to screen for breast cancer in the 27 months prior to the end of the Measurement Period
CMS127: Pneumococcal Vaccination Status for Older Adults:
Percentage of patients 65 years of age and older who have ever received a pneumococcal vaccine
CMS130: Colorectal Cancer Screening:
Percentage of adults 50-75 years of age who had appropriate screening for colorectal cancer
CMS147: Preventive Care and Screening: Influenza Immunization:
Percentage of patients aged 6 months and older seen for a visit between October 1 and March 31 who received an influenza immunization OR who reported previous receipt of an influenza immunization
CMS153: Chlamydia Screening for Women
Percentage of women 16-24 years of age who were identified as sexually active and who had at least one test for chlamydia during the measurement period
Description of Issue:
Some eCQMs include QRDA-1 reporting guidance in the header. CMS publishes QRDA-1 Implementation Guides (e.g. 2022 CMS Quality Reporting Document Architecture (QRDA) Category I Implementation Guide (IG) (https://ecqi.healthit.gov/sites/default/files/QRDA-HQR-2022-CMS-IG-508.pdf)), which should serve as the primary guidance and source of truth.
To avoid redundancy, we propose removing QRDA-1 statements from the headers.
Proposed Solution:
Below are statements that we propose to remove from the measures:
CMS124
"Patient self-report for procedures as well as diagnostic studies should be recorded in 'Procedure, Performed' template or 'Diagnostic Study, Performed' template in QRDA-1."
CMS125
"Patient self-report for procedures as well as diagnostic studies should be recorded in 'Procedure, Performed' template or 'Diagnostic Study, Performed' template in QRDA-1."
CMS127
Patient self-report for procedures as well as immunizations should be recorded in 'Procedure, Performed' template or 'Immunization, Administered' template in QRDA-1.
CMS130
Patient self-report for procedures as well as diagnostic studies should be recorded in "Procedure, Performed" template or "Diagnostic Study, Performed" template in QRDA-1.
CMS147
Patient self-report for procedures as well as immunizations should be recorded in 'Procedure, Performed' template or 'Immunization, Administered' template in QRDA-1.
CMS153
Patient self-report for procedures as well as diagnostic studies should be recorded in 'Procedure, Performed' template or 'Diagnostic Study, Performed' template in QRDA-1. Patient self-report is not allowed for laboratory tests.
Rationale for Change:
This change will remove redundant guidance from measure headers and avoid redundancy with existing guides published to aid implementation. **